1. Home
  2. BMHL vs TNYA Comparison

BMHL vs TNYA Comparison

Compare BMHL & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluemount Holdings Limited Class B Ordinary Shares

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

HOLD

Current Price

$5.79

Market Cap

152.9M

Sector

N/A

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
TNYA
Founded
2016
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
168.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
BMHL
TNYA
Price
$5.79
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
919.0
1.9M
Earning Date
06-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$66.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$0.53
52 Week High
$6.35
$2.35

Technical Indicators

Market Signals
Indicator
BMHL
TNYA
Relative Strength Index (RSI) 56.91 47.03
Support Level $5.58 $0.66
Resistance Level $6.35 $0.82
Average True Range (ATR) 0.23 0.03
MACD 0.01 0.00
Stochastic Oscillator 87.00 56.85

Price Performance

Historical Comparison
BMHL
TNYA

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: